Tag: Pcsk9 inhibitors

In a study of over 25,000 middle-aged adults with no known heart disease, over 42% were found to have atherosclerosis (plaque buildup) [1.8.4]. So, what drug removes plaque from arteries and how can this condition be managed?

According to Drugs.com, one common capsule with the imprint **PC9** contains a combination of acetaminophen, dextromethorphan, and phenylephrine, an over-the-counter remedy for cold and flu symptoms. However, the query "What drug is PC9?" can also point to a different class of cholesterol-lowering drugs called PCSK9 inhibitors or a cancer cell line used in research, requiring context to correctly identify the specific reference.

Over 92 million adults in the US take statins, a class of medication crucial for managing cholesterol and heart disease. When considering what drug clears plaque from arteries, it's important to understand that no single pill provides a quick, easy fix, but certain therapies can significantly impact plaque stabilization and reduction.

According to the European Medicines Agency (EMA), several effective non-statin medications are approved for patients with high cholesterol. These therapies provide vital alternatives for individuals unable to tolerate statins or who require further low-density lipoprotein cholesterol (LDL-C) reduction. The question of **what does Europe use instead of statins** reveals a landscape of modern pharmaceutical options complementing or replacing traditional statin use.

About 86 million U.S. adults have total cholesterol levels over 200 mg/dL [1.4.2]. For many, medication is essential for management, which raises a critical question: which cholesterol drug is safest?

Approximately 15 percent of people experience side effects, such as muscle aches, from statin medications, leading to discontinuation of treatment. This has fueled the development of newer alternatives, such as the **new cholesterol drug that is not a statin**, offering new hope for effective lipid management.